New Leaf Venture Partners — Full Portfolio
31 tracked investments · listed companies and verified rows first
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Kevin M. King(Executive Officer, Director)inShelly D. Guyer(Executive Officer)inWilliam F. Willis(Executive Officer, Director)Judith Lenane(Executive Officer)Steve Johnson(Executive Officer)in
BoardTiba Aynechi(Director)in
Board seatVijay Lathi· per SEC Form D · $29.5M raise · filed Mar 2015
Co-investorsKaiser Permanente VenturesNorwest Venture PartnersSt. Jude Medical
Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions.
BiotechHealthtechPhiladelphia, US
William Chou(Chief Executive Officer)Tadataka Yamada(Executive Officer, Director, Promoter)Stephen Squinto(Executive Officer, Director)in
BoardPatrick Heron(Director)inCarl Gordon(Director)inThomas Street Address 1 Woiwode(Director)
Co-investorsFrazier Life SciencesAccess BiotechnologyFrazier Healthcare PartnersOrbiMedVersant VenturesVivo Capital
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation – JJDCPappas Capital+2 more
Real-time asset tracking and workflow monitoring in healthcare
San Diego, US
Brandon Hull(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)Emily Wilson(Executive Officer)Paul Wallace(Director)Dana Mead(Director)
Board seatVijay Lathi· per SEC Form D · $1.9M raise · filed Aug 2017
Co-investorsIcon VenturesRex Health VenturesHERITAGE HEALTHCARE INNOVATIONKleiner PerkinsVenrock
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Board seatVijay Lathi· per SEC Form D · $16.8M raise · filed Mar 2022
Co-investorsBattery VenturesBreyer CapitalDigiTx Partners LLCInsight PartnersLRVHealthEsplanade Ventures+4 more
Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects.
HealthtechMedical DevicesWoburn, US
Gregory H. Lambrecht(Director)Carey Hagan(Executive Officer, Director)Cary Hagan(Executive Officer, Director)
BoardRyan Drant(Director)inJoshua Makower(Director)
Board seatJeani Delagardelle· per SEC Form D · $7.5M raise · filed Apr 2023
Co-investorsDelos CapitalNew Enterprise Associates (NEA)Questa CapitalGreenspring Associates
Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.
AI & Machine LearningEnterprise SoftwareHealthtechWashington, US
Kevin MacDonald(Executive Officer)inTimothy Kress-Spatz(Executive Officer)
Board seatVijay Lathi· per SEC Form D · filed Jun 2016
Co-investorsEaston CapitalKaiser Permanente VenturesLionBirdRex Health VenturesRock Health
Kyruus Health provides a healthcare access platform that unifies provider and member data to help patients find, schedule, and access care.
Digital HealthHealthtechSaaSBoston, US
Graham Gardner(Executive Officer, Director)inJulie Yoo(Executive Officer, Director)inGraham Gardner, MD, MBA(Founder)in
BoardRobert Paull(Director)inRobert Higgins(Director)Bryan Roberts(Director)
Board seatVijay Lathi· per SEC Form D
Co-investorsF-Prime CapitalFrancisco PartnersTRANSFORMATION CAPITALVenrockHighland Capital PartnersLux Capital+1 more
Truveris offers a technology platform with claims analytics and PBM (pharmacy benefit manager) oversight to reduce pharmacy benefit costs through contract optimization for employers.
Data & InfrastructureDigital HealthHealthtechSaaSNew York, US
Anthony Joseph Loiacono(Executive Vice-President, Sales and Marketing)Michael Facendola(Executive Officer)inLouise Shea(Chief Pharmacy Officer)inBryan Birch(Chief Executive Officer)in
BoardPhilippe Chambon(Director)Stephen M. Bloch(Director)in
Board seatVijay Lathi· per SEC Form D
Co-investorsCanaan PartnersMcKesson VenturesNAV.VCTribeca Venture Partners
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more
BiotechSan Carlos, US
Anthony P. Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)Liam Ratcliffe(Director)in
BoardRon Hunt(Director)inLoretta Tse, Ph.D.(Director)
Co-investorsAlta Partners
Deciphera is a pharmaceutical company focused on developing treatments for people living with cancer.
Biotech
Daniel Flynn(Founder)in
Co-investorsFrazier Life SciencesREDMILEViking Global Investors
Dimension Therapeutics was a Cambridge, Massachusetts biopharmaceutical company developing AAV-based gene therapies for rare liver-associated metabolic diseases like hemophilia, OTC deficiency, and glycogen storage disease.
Cambridge, US
Annalisa Jenkins(Executive Officer, Director)
BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)
Co-investorsF-Prime CapitalOrbiMed
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesGenesys CapitaliGan PartnersRBCx
Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.
BiotechCambridge, US
Gabriel Kwong(Executive Officer)inSangeeta BhatiainRoopom Banerjee(Executive Officer)in
BoardTheresia Gouw(Director)inAmy Schulman(Director)inStan Lapidus(Director)in
Co-investorsGreatPoint VenturesAcrew CapitalAspect VenturesCatalio Capital ManagementCRV (Charles River Ventures)Dns Capital+4 more
A research-intensive biopharmaceutical company that develops medicines and vaccines.
BiotechHealthtechSouth San Francisco, US
Luke Nathaniel Walker(Executive Officer)Julie Eastland(Executive Officer, Director)in
BoardRonald Hunt(Director)Mark Chin(Director)Alan Colowick(Director)Jonathan Drachman(Director)
Co-investorsK2 HealthVenturesTaiho Ventures, LLCArix BioscienceLilly Asia VenturesMPM BioImpactOrbiMed
Kit is a pocket money app and debit card built by CommBank for children to earn pocket money, save towards goals, and track spending, while parents monitor spending, set limits, and manage multiple children's accounts.
ConsumerEdTechFintechAustralia, AU
Co-investorsx15ventures (Commonwealth Bank)Kaiser Permanente VenturesSands Capital Ventures
BiotechSan Francisco, US
Philip Fung(Executive Officer, Director)
BoardRoberto Sanabria(Director)in
Co-investorsExpaEaston Capital Investment GroupKaiser Permanente VenturesLionBirdSands Capital Ventures
BiotechSouth San Francisco, US
MARTIN BABLER(Executive Officer, Director)in
BoardPETER THOMPSON(Director)inSRINIVAS AKKARAJU(Director)MICHAEL DYBBS(Director)inSIMEON GEORGE(Director)LEWIS J. SHUSTER(Director)
Co-investorsAccess BiotechnologyMission BiocapitalSofinnova VenturesMission Bay CapitalOrbiMedSamsara BioCapital+1 more
Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.
BiotechMedical DevicesDedham, US
Thurein Htoo(Executive Officer, Director)inFred Guerard(President & Chief Executive Officer)inBarbara Wirostko(Executive Officer)
BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)
Co-investorsCanaan Partnersabrdn plcCorrelation VenturesMayo Clinic Ventures
BiotechGreenwhich, US
Wendy DiCicco(Ms. DiCicco is the Secretary and Treasurer of the Issuer.)inArthur Feldman(Director)Magdalene Cook(Executive Officer, Director)Campbell Murray(Director)Edward J. Benz, Jr.(Director)Thomas Needham(Director)in
Co-investorsBioAdvanceElysia CapitalBroadview VenturesInnogest CapitalNovartis Venture Fund
Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.
ConsumerMedia & Entertainment
Co-investorsAndera PartnersBrace PharmaOrbiMedWellcome Trust
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AIC Innovations GroupReshape MedicalAdvanced Cell DiagnosticsBenefit SolutionsBraeburn PharmaceuticalsCardioKinetixDirect Flow MedicalTrue North Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.